chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt stated she had red face, swollen face and an exfoliating feeling on her face. Resolved itself after 24 hours.
10 minutes after getting vaccine pt stated he was getting dizzy and felt short of breath. He lost consciousness for about 30 seconds, was shaking and gasping for air. We laid him on the ground and did a sternal rub and called 911. Patient was breathing on his own during this time and started to gain consciousness. EMTs then arrived on the scene and placed him on oxygen.
I am having terrible pain after I received my second vaccine; When I get up in the morning I have terrible pain in my shoulders, wrists, hips, ankle; I must have had the virus at some point with very mild; I smell smoke; This is a spontaneous report from a contactable consumer (patient). A patient of an unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: Unknown) via an unspecified route of administration on 16Apr2021 as second dose, single for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: Unknown) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. On an unspecified date, the patient was having terrible pain after receiving second dose of vaccine. Patient reported that when patient gets up in the morning, have terrible pain in shoulders, wrists, hips, ankle and general muscle pain. Patient could barely get up in the AM, the pain was so bad and smelled smoke. Patient was told on Friday at the hospital they must have had the virus at some point with very mild reactions. Patient wanted to know that what can be done about the pain. Patient thought that Pfizer will be hit with a class action suit. Outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
About 5-7? after vaccine, had high heart rate (155 on her smart watch). Also had intermittent dizziness. Brought over to a cot,  took vitals once on cot 2 minutes. Bp130/82 (pt reports that is a little high for her), pulse 96, RR 14/min. Recovered within 35 minutes, asked to leave because she felt better. Called pt. @ 12:15pm and she stated, ?I feel totally fine, my heart rate is 80 or less like normal and not at all dizzy.?
Expired vaccine was stored and then administered; Dose was given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date) and PRODUCT STORAGE ERROR (Expired vaccine was stored and then administered) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vaccine was stored and then administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date) and PRODUCT STORAGE ERROR (Expired vaccine was stored and then administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  Reporter stated that vaccine did not undergo any temperature excursion and patient did not experienced any adverse event and the date vaccine placed in refrigerator was on 04-Nov-2021.
pt recvd vax & exp dizziness, h/a & called MD; also exp nausea, lightsensitivity, joint pain;
Information has been received from a 39 year old male patient who was in the hospital for a hip replacement. He had a chest x-ray and then received a dose of PNEUMOVAX 23 (March 2007). The patient believed that it was PNEUMOVAX 23 (lot# 651356/0089F) but was not positive. Shortly afterward he developed respiratory complications in March 2007. The patient reported it required hospitalization. Additional information has been requested.
I received the Pfizer EK5730 shot at about 11:30 am on 12/28/2020. When I walked out of the office from getting the shot I started feeling like I had walked mile but I was ok. At about 4:00 PM I started feeling some tightness on my chest and some aching like a pulsing aching on my chest. I felt like I had some energy but I also felt I was paying to mush attention to my symptoms. I lay down at 8:30 PM and I fallen to sleep on the couch. When I got up this morning as stood up from my bed my legs were hurting and I feel exhausted. I just want to cuddle and go back to sleep. I force myself to make it to work but I am dealing with leg pain and very very tired with a slight headache and chills.
Redness and itching on leg around injection site starting 3 days after and improving 3 days later
The injection site was red, swollen, and painful to the touch. An MD gave a prescription antibiotic in case it was cellulitis.
No additional AE; pediatric dose of RECOMBIVAX HB was inadvertently given to an adult; pediatric dose of RECOMBIVAX HB was inadvertently given to an adult; This spontaneous report was received from a nurse referring to an adult patient of unknown gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided.      On 03-MAR-2022, the patient was vaccinated with a pediatric dose of hepatitis b vaccine (recombinant) thimerosal free (RECOMBIVAX HB) 0.5 milliliter, lot number U005271, expiration date 21-NOV-2022 for prophylaxis (route of administration not provided) (incorrect dose administered and product administered to patient of inappropriate age). No adverse event was reported.
Per hospital reporting system "Within 5 mins of patient getting  Vaccine patient told nurse she was feeling numbness and tingling in her face. Nurse propped patient's feet up on chair got CTL to come to the room where the event was happening. Vitals was checked (BP was high and Pulse was high) cool rag was placed on patient's forehead and Provider came to access patient. Patient was kept for an hour with vitals being accessed and then released to go home with son."
8 hours after vaccine patient developed body aches, fever 99.6 and cellulitis. Keflex given for cellulitis
After being vaccinated I noticed a red bruise on my upper right thigh. This happened with my 4th dose as well.
Itchy; Red; A spontaneous report was received from a consumer concerning a 79-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced red and itchy.   The patient's medical history was not provided.  No relevant concomitant medications were reported.  On 28 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot Number: 309K209) in right arm for prophylaxis of COVID-19 infection.   On 4-JAN-2021, the patient experienced injection site redness and itchiness.    No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, red and itchy was considered not recovered/resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
1) Severe headache and delirious sleep and overall muscle achiness. Lasted for 36 hours approx. 2) Approx ten days later on April 19th, 2021, I awoke at night with severe left shoulder pain/deep ache. It came and went over the next week, but became more constant and severe. I couldn't sleep most nights without sleep meds, and even then it was for a few hours, and on my back. I couldn't sleep on either the good and especially not the bad shoulder.  Via a phone call, my PCP suggested I begin treatment with Ibuprofen, 3-4 times per day. I took 2-3 Ibuprofen at a time. As of today, May 12, 2021, I am still taking Ibuprofen 3 times a day as I still cannot sleep on my bad (left) side. I didn't think this was related to the vaccine shot until my husband said that he also was having shoulder pain on the same side as the injection. His was milder and lasted about a week, but began about the same time as mine did.
Patient had a significantly large red, hard area that was warm to the touch and approximately 3 inches in diameter at the injection site.
08/25/22 presents to ED for "vomiting". PMHx of "COVID, ADHD, Panic attacks, and haluciniations"
Complain of itchy rash, noticed one day after receiving measle, mumps and rubella vaccine, temperature 98.6 "red patches" noted on right arm a few on left upper arm, thighs, ankles, and back at waist band.  Nurse Practitioner referred to primary care provider and suggested antihistamine (over counter).
Accident at work; Foot injury; Lethargic; Vaccination site pain; This spontaneous case was reported by a non-health professional and describes the occurrence of ACCIDENT AT WORK (Accident at work), LIMB INJURY (Foot injury), LETHARGY (Lethargic) and VACCINATION SITE PAIN (Vaccination site pain) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    No Medical History information was reported.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In June 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced ACCIDENT AT WORK (Accident at work), LIMB INJURY (Foot injury), LETHARGY (Lethargic) and VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, ACCIDENT AT WORK (Accident at work) and LIMB INJURY (Foot injury) was resolving and LETHARGY (Lethargic) and VACCINATION SITE PAIN (Vaccination site pain) had resolved.     Concomitant product use was not provided by the reporter.  On unknown dates, the patient experienced workman comp accident, ladder ran over foot on 7/7 and very lethargic and sore arm after taking Covid vaccine.   Patient reported workman comp accident, ladder ran over foot on 7/7. He was very lethargic and had sore arm after taking Covid vaccine.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  The reporter's causality events of workman comp accident, ladder ran over foot on 7/7, very lethargic and sore arm after taking covid vaccine and workman comp accident, ladder ran over foot on 7/7 with Skyrizi (Risankizumab) was no reasonable possibility. The reporter's causality for the events of very lethargic and sore arm after taking Covid vaccine unknown onset was not provided.  Treatment information was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Pharmacist noticed after the vaccine was given that the beyond use date had expired, beyond use date shows 4/4/23 but vaccine administered on 4/10/23. Spoke with the patient the following day and stated her arm was sore but no other reactions.
Marked increase in Tinnitus, in both ears.  Onset in left ear soon after vaccine, spread to right ear that evening, and has persisted since.
Pain, redness and swelling around injection site, approx size of half dollar coin; fatigue; joint pain; diarrhea; nausea
This spontaneous prospective pregnancy report as received from a other health professional refers to a female patient of unknown age. On an unknown date the patient was vaccinated with VARIVAX for prophylaxis.  The patient became pregnant. The LMP and EDD is not known. The patient delivered a infant. The pregnancy outcome was unknown. On an unknown date the patient experienced occupational exposure to product, exposure via skin contact, accidental exposure to product, no adverse event and maternal exposure during pregnancy. The outcome of occupational exposure to product, no adverse event, maternal exposure during pregnancy, exposure via skin contact and accidental exposure to product is unknown. The reporter considered occupational exposure to product, exposure via skin contact, accidental exposure to product, no adverse event and maternal exposure during pregnancy to be not related to VARIVAX. {Additional information has been requested. / Additional information is not expected.}
VAX RECVD 1ST AND 2ND DOSE ON 4-17-90 AND ON 5-17-90 RESPECTIVELY. ON EACH OCCASION THE DAY AFTER INJECT PT EXP WATERY EYES, IRRATABILITY, RUNNY NOSE, SNEEZING, CONGESTION. CLEARED AFTER BENADRYL TAKEN.
1. Acute hypoxic respiratory failure: secondary to pneumothorax and atelectasis with underlying COPD. Seems less likely related to COVID-19. Weaned to RA today, normal work of breathing, no wheezing or rales on exam, and CXR with re-expanded lung with continued atelectasis. Continue IS. If remains stable on RA ok to discharge .   2. Spontaneous secondary pneumothorax: secondary to underlying COPD. CT surgery evaluated as this is the patients second pneumothorax related to emphysema. They are planning possible VATS mechanical and chemical pleurodesis after discharge when he is out of COVID-19 isolation. CXR ordered for two weeks after discharge and follow up with Dr. to be arranged. Pulmonary removed chest tube 3/1/23 and has now signed off.   3. COVID-19: vaccinated 5 x with most recent 10/2022. No clear covid specific symptoms PTA and no way to determine start of infection (cough started 2/27 - likely d/t pneumo ). S/p remdesivir 3 day course.    4. Pulmonary nodule: CXR noting possible right lower lung lesion. CT obtained before discharge due to prior smoking history and elevated cancer risk. Noted stable 7 mm RUL nodule.   5. Tobacco use disorder: cessation recommended
On 10/30 (10 days after vaccination) patient reported that had pain in left shoulder that started approximately 12 hours after the injection. And he sent a photo of where the Band Aid had been placed. Complained of pain at night as well as with some range of motion. Seen by PCP who contacted ortho physician - determined injection possibly went into bursa and should resolve with MEDROL. Pain persisted so patient was seen by ortho physician on 11/8 who said it was possible intra-bursa ortra-articular injection. Feels should have a full recovery in 3-4 weeks with full range of motion.
<5mins p/shot, limp, lethargic although responsive to unpleasant stimuli, hypotonic & dec spontaneous movements but neuro exam otherwise intact;glucose 80; adm to hosp for observation;EEG, electrolytes;
Chills; she had a temperature; This is a spontaneous report from a contactable consumer or other non hcp (patient) and physician. A 67-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported), via an unspecified route of administration on 24Feb2021 (at the age of 67-year-old) as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 24Feb2021, the patient experienced chills, she had a temperature. This consumer was administered her second dose of Pfizer COVID-19 Vaccine 24Feb2021. She was doing good the whole entire evening until late evening; she started to feel chills around 20:00-21:00. Through the night she had a temperature, so she took 2 Tylenol. She has no pain in her arm where the Pfizer COVID-19 Vaccine was given; but she has a temperature. She does not know what to take, she asked if she should take Tylenol or something else for her temperature. The patient received Tylenol as treatment for the events. The patient underwent lab tests and procedures which included had a temperature on 24Feb2021. The outcome for the events was unknown.  Information about lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
I began itching a little bit across my shoulders after my first dose but after my second dose I began to itch more intensely and it started in my back as well. I still have itching to this day.
migraine, got really hot and sweating   and nauseas. could not keep anything down for 2 days and my entire body was sore. took tylenol  for the migraine but did not help
Pt recvd 3 doses of Engerix-B 02MAR90, 06APR90, & 06SEP90 & it was determined that pt failed to seroconvert;
At 1340 patient received HepA/HepB. Patient then put his top back on and went to sign out. While signing out he lost consciousness and hit the back of his head. EMS was activated. Patient's vitals were BP 112/74, Pulse 98, 02 96%. EMS arrived at 1345.
Pt recv vax on 3/6/99; on 4/3/99 pt exp red/ raised lesions on right upper thigh, abdomen, back
Feels like she might die; This is a spontaneous report from a contactable consumer reporting for herself. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration on an unspecified date as unknown dose single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, the patient feels like she might die. It was reported that "she got the shot, and they gave her the brochure and it said not to take any other vaccines before getting it and they did not tell her that. Because if she dies someone needs to know". Outcome of the event was unknown.  Information about lot/batch number has been requested.
revealed Breast cancer biomarkers 3 fold elevated (81) and CEA was 3.0 which was doubled; revealed Breast cancer biomarkers 3 fold elevated (81) and CEA was 3.0 which was doubled; This is a spontaneous report received from a contactable physician. This physician (patient) reported for herself that a 69-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685) via an unspecified route of administration in left arm on an unspecified date (reported as on 19Dec2020, pending clarification) at single dose for COVID-19 immunization, in hospital. Medical history included breast cancer survivor-Stage 1A, grade 1; was treated with surgery and radiation in 2017 and opposite side in 2018 with surgery and radiation; sulfa allergy and cephalosporin allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient was not pregnant at time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included anastrozole and atorvastatin (LIPITOR). The patient historically received first single dose of BNT162B2 (lot number: EJ1685) via intramuscular in left arm on 19Dec2020 10:00 for COVID-19 immunization. Patient reported that she had breast cancer and was treated with surgery and radiation in 2017 and opposite side in 2018 with surgery and radiation. Currently on anastrozole. On routine surveillance test 2 months after the vaccine revealed Breast cancer biomarkers 3 fold elevated (81) and CEA was 3.0 which was doubled. 5 weeks later repeat tests showed CA marker 77 and CEA 2.6. Normally her markers run between 22 and 30 and CEA between 1.5 and 2.2. Should she worried about this and recurrence. She was in a very good health otherwise post cancer treatment. The adverse event occurred on 15Mar2021 08:00, resulted in doctor or other healthcare professional office/clinic visit, no treatment was received. Outcome of the event was not recovered. Since the vaccination, the patient has not been tested for COVID-19.   No follow-up attempts are needed. No further information is expected.; Sender's Comments: Based on the information provided by the reporter, it appears unlikely that subject vaccine contributed to the events.  The reported events likely represent intercurrent medical conditions.   There is limited information provided in this report. This case will be reassessed upon receipt of follow-up information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Neuropathy in the legs got worst; Hearing loss; Protein in the urine (undergone test); Pain on the groin each side; So much pain in the back; This is a spontaneous report from a contactable consumer (patient). An 81-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single; and via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation. Medical history included transplant patient. The patient's concomitant medications were not reported. Patient reported to be a transplant patient who got both doses of the COMIRNATY vaccine. Post-vaccination, she reported that she had experienced the following adverse events (AEs) on an unspecified date: protein in the urine (undergone test), neuropathy in the legs got worst, pain on the groin each side, so much pain in the back, and hearing loss. The patient has to stay in one place all night long because of the pain (had to undergo laminectomy); the neurosurgeon had to give codeine and acetaminophen and a muscle relaxer for the pain. In line with the side effects she had experienced, the patient would like to know if it's recommended that she get her booster/third dose. She would also like to know if the side effects of the booster dose are the same as that of the first 2 doses. Being that they have found protein in her urine, patient would like to know if the vaccine contains any protein. Patient would like to know if the booster dose/third dose has the same ingredients as the first 2 doses and would like to have lists of risks associated with the COMIRNATY vaccine be sent to her. The patient was referred to the healthcare professional (HCP). The outcome of the events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Information has been received from a physician concerning an "about 9 weeks old" female who in October 2008, was vaccinated orally with a 2 ml dose of ROTATEQ vaccine. In October 2008, "a day after vaccination", the patient experienced severe diarrhea and vomiting, however, the patient did not have a fever. Unspecified medical attention was sought. At the time of this report, the outcomes were unknown. follow-up information has been received from a physician concerning the patient, who started with vomiting and diarrhea the day the vaccine was received, lasting for about 2 or 3 days. No further information is available.
Swollen red injection site, extreme tired, stomach cramps, neck and back spasms/pain(like a Charlie horse in neck)still swollen hurting 4 days later neck still hurting 4 days later
Patient recieved vaccine suffered from Vaso Vagal response. He was put in prone position with feet up on chair.  Onsite EMS was called vitals BP 116/60  HR 64. Patient mom stated family history of vasovagal resposes. Patient recovered and went home.  New call at 12:30 pm at patient  in the car with his mom faints. Onsite EMS was called he was very pale. Vitals HR 68  BP 105/68 he was given water then Coke-Cola color returned to face. Patient waited 20 minutes then went home. Mom was told to call 911 if he faints again.